Inhibition of In-Vivo Platelet Deposition following Experimental Angioplasty by a Locally Delivered Antibody Targeted Antiplatelet-Fibrinolytic Conjugate

Anticoagulation after intracoronary stent insertion.

“…In addition limitation of thrombin generation may have an important impact on subsequent smooth muscle cell proliferation. 23 Other groups in Europe are using low molecular weight heparin or ticlopidine, and some are starting trials to compare ticlopidine with aspimn.…”